However, QE-induced mitochondrial fusion and Pink1/Parkin-dependent mitophagy may negatively influence its anticancer effects in HCC and targeting mitophagy may enhance the therapeutic potential of QE in HCC treatment (Chen, 2024). This evidence concerns the gene PRKN and hepatocellular carcinoma.